Jeremy O'Sullivan

Research Assistant Professor

Northwestern University Feinberg School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jeremy O'Sullivan is a Research Assistant Professor at Northwestern University Feinberg School of Medicine in the United States. His research focuses on understanding the interactions of Siglec-8, TGFβ sensitivities in T cell subsets, and drug delivery strategies for mast cell diseases. He has contributed to several recent articles exploring the implications of Siglecs in allergy and asthma, as well as their potential as therapeutic targets in eosinophil-associated diseases.

Articles (16)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Jose Alejandro Guevara-Patino

Professor

Moffitt Cancer Center

UNITED STATES

View details

Eva Knuplez, PhD

Medical University of Graz

AUSTRIA

View details

Bruce S. Bochner

Samuel M. Feinberg Professor of Medicine

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

Evan Scott

Kay Davis Professor

Northwestern University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeremy O'Sullivan

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Drug delivery targets and strategies to address mast cell diseases

Siglecs in allergy and asthma

Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGFβ

Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells.

Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells

Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGFβ

NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells

NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells

Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases

Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases

Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells

Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death In Vitro

Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls

Discovery, Function, and Therapeutic Targeting of Siglec-8

Eosinophil and mast cell Siglecs: From biology to drug target

Single-site, five-year experience with human eosinophil isolation by density gradient centrifugation and CD16 immunomagnetic negative separation

Collaborators (4)

Jose Alejandro Guevara-Patino

Eva Knuplez, PhD

Bruce S. Bochner

Evan Scott

Make your next move.